A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours
Clinical trial NCT03468426 · COMPLETED
Trial details
- NCT number
- NCT03468426
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-05
- Primary completion
- 2024-07-31
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.